Synteract®, a Syneos Health® company, is a leading full service CRO focused on the emerging biopharma segment. The Company’s multidisciplinary teams support biotech and pharmaceutical companies across all phases of drug development, providing deep expertise in oncology, dermatology, general medicine, infectious disease and vaccines, neuroscience, pediatrics, and rare and orphan diseases. Synteract has conducted nearly 4,000 studies on six continents in over 62 countries.
Company Details
- Employees
- 192
- Address
- 430 Davis Dr, Suite 500,germany
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- synteract.com
- Keywords
- CRO, Life Sciences, Biotech, Oncology, Clinical Trial Services, CNS/Neuroscience, Rare and Orphan Disease, Pediatrics, Clinical Development Services, Ophthalmology, Immunotherapy, Phases I-IV, dermatology.
- HQ
- Morrisville, North Carolina
Synteract Questions
Synteract's website is synteract.com
Synteract's LinkedIn profile is https://www.linkedin.com/company/synteract
Synteract has
192 employees.
View email and phone details for 192
employees at Synteract.
Synteract's industry is
Biotechnology Research
Synteract's top competitors are
Fortrea,
Iqvia,
Illingworth Research Group (A Syneos Health Company),
Medpace,
Ppd,
Icon Plc,
Parexel,
Inc Research,
Syneos Health,
Premier Research.
Synteract's categories are Biotechnology Research
